Sudarshan Chem Q2: PAT ₹30.5 Cr (consol) as ₹82.9 Cr one-off masks OPM rebound to 9.7%
PAT +58% YoY · revenue +14.9% · margins expanding
₹2,742.6 Cr
+14.9% YoY
₹30.5 Cr
+58% YoY
1.11%
+0.3pp YoY
₹3.5
Sudarshan Chemical's consolidated (primary) Q2 FY27 revenue came in at ₹2,742.6 Cr, up 14.9% YoY (₹2,387.4 Cr) and 3.8% QoQ (₹2,642.1 Cr), with reported PAT of ₹30.5 Cr (owners' share ₹27.6 Cr) — up 58.0% YoY off a weak ₹19.3 Cr base but down 70.5% QoQ from ₹103.4 Cr. The YoY PAT comparison is not clean: this quarter carries a ₹82.9 Cr exceptional pre-tax charge (₹74.5 Cr employee termination/restructuring cost at a German overseas subsidiary plus ₹8.4 Cr of costs from reclassifying VP4 Frankfurt GmbH as held-for-sale) that the year-ago and prior quarters did not have. Stripped of that charge, pre-exceptional PBT was ₹154.3 Cr versus a reported ₹71.4 Cr — adjusted PAT works out to roughly ₹113 Cr against last year's ₹19.3 Cr, though the comparison is exaggerated by how thin that year-ago base was.
Q2 FY-2027 vs prior quarters
The margin bridge tells the real operating story: consolidated EBITDA margin (OPM) expanded to 9.7% from 5.5% a year ago — in line with last quarter's 9.8% — while net margin (NPM) was just 1.1%, down from 3.9% last quarter and barely above last year's 0.8%, entirely because the one-off sits above the tax line this quarter. Standalone (parent-only, ex-Heubach) PAT was ₹61.0 Cr on ₹777.2 Cr revenue with no exceptional items at all — the gap to consolidated reflects scope (the acquired global pigments business sits outside the standalone entity), not a conflicting signal.
The stock went into the print at ₹1,073.55, down 12.5% over the past month of trading.
What the summary numbers don't show
Basic EPS ₹3.5 after exceptional items (₹13.9 before), vs ₹12.3 last quarter and ₹1.5 a year ago.
FY27 acquired group: EUR 700M turnover, EUR 35M EBITDA (reaffirmed, no revision despite Q1 beat). Long-term: 7x 2023 EBITDA (~₹1,400+ Cr), debt-free trajectory. Near-term caution due to geopolitical uncertainty; revisit guidance after Q2.
No reliable Street consensus for this specific quarter's numbers turned up in search, so vs-Street is left unknown rather than guessed. On guidance: management's prior concall (20-Aug-2026) reaffirmed FY27 guidance for the acquired Heubach group (EUR 700M turnover, EUR 35M EBITDA) despite a Q1 beat, flagged geopolitical caution, and said it would revisit guidance after Q2 — this filing contains no management commentary or press release addressing that guidance, so vs-guidance is unknown rather than confirmed met or missed. On corporate activity: the VP4 Frankfurt GmbH stake sale (agreed 31-Aug-2026, EUR 75.8 million) is the direct source of part of this quarter's exceptional charge and formally completed 2-Nov-2026, after the quarter closed; separately, Sudarshan completed a ₹150.76 Cr buy-in of an additional 15.89% stake in Sudarshan Colorants India (formerly Heubach Colorants India) effective 1-Oct-2026, taking group holding to 70.26% — both are subsequent/period-adjacent events, not yet reflected in this P&L beyond the disposal-related costs already booked. Two GST inspections at Maharashtra units (Oct 2026) show no associated provision in these results.
W1
Whether the 9.7% consolidated OPM holds or improves in Q3 FY27 now that the ₹82.9 Cr restructuring/disposal-related exceptional charge is largely behind the group.
W2
Any revision to FY27 guidance for the acquired Heubach group (EUR 700M turnover / EUR 35M EBITDA) — management flagged a review 'after Q2' for geopolitical caution, but this filing carries no update.
W3
P&L/cash treatment of the completed VP4 Frankfurt disposal (EUR 75.8 million, closed 2-Nov-2026) and the Sudarshan Colorants India stake move to 70.26%, both landing in Q3 FY27 accounts.
Informational and educational content only. Not investment advice.